Nexalin Technology (NXL) Change in Receivables (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Change in Receivables of -$755.0 for Q1 2026, down 172.6% year-over-year from $1040.0 in Q1 2025, and down 102.11% quarter-over-quarter from $35833.0 in Q4 2025.
Nexalin Technology (NXL) Change in Receivables (2021 - 2026) Analysis & Trends
Nexalin Technology's Change in Receivables history runs 6 years deep, the most recent figure standing at -$755.0 for Q1 2026.
- In Q1 2026, Change in Receivables fell 172.6% year-over-year to -$755.0; the TTM figure through Mar 2026 stood at $31927.0 (up 406.62% YoY), while the FY2025 annual figure was $33722.0, changed N/A from the prior year.
- Change in Receivables for Q1 2026 stood at -$755.0, down from $35833.0 in the prior quarter.
- The five-year high for Change in Receivables was $53540.0 in Q1 2022, with the low at -$51916.0 in Q3 2025.
- The 5-year median for Change in Receivables is $30.5 (2023), against an average of $2428.5.
- Peak annual rise in Change in Receivables reached 9314.09% in 2025, while the deepest fall reached 1171.76% in 2025.
- Nexalin Technology's Change in Receivables stood at -$5477.0 in 2022, then tumbled by 59.36% to -$8728.0 in 2023, then surged by 155.5% to $4844.0 in 2024, then jumped by 639.74% to $35833.0 in 2025, then plunged by 102.11% to -$755.0 in 2026.
- Business Quant data shows NXL's Change in Receivables at -$755.0 in Q1 2026, $35833.0 in Q4 2025, and -$51916.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Nexalin Technology | 7.01 Mn | 6.00 Mn | 8,897.00 | -27,886.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27,886.00 |
| Jun 30, 2026 | -27,886.00 |
| Mar 31, 2026 | -755.00 |
| Mar 31, 2026 | -755.00 |
| Dec 31, 2025 | 35,833.00 |
| Dec 31, 2025 | 35,833.00 |
| Sep 30, 2025 | -51,916.00 |
| Sep 30, 2025 | -51,916.00 |
| Jun 30, 2025 | 48,765.00 |
| Jun 30, 2025 | 48,765.00 |
| Mar 31, 2025 | 1,040.00 |
| Mar 31, 2025 | 1,040.00 |
| Sep 30, 2024 | 4,844.00 |
| Sep 30, 2024 | 4,844.00 |
| Jun 30, 2024 | 518.00 |
| Jun 30, 2024 | 518.00 |
| Mar 31, 2024 | -100.00 |
| Mar 31, 2024 | -100.00 |
| Dec 31, 2023 | -8,728.00 |
| Dec 31, 2023 | -8,728.00 |